Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes.
about
The impact of weight gain on motivation, compliance, and metabolic control in patients with type 2 diabetes mellitus.Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factorsComparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian.13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.Ginseng on hyperglycemia: effects and mechanismsInsulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.Meta-analysis and critical review on the efficacy and safety of alpha glucosidase inhibitors in Asian and non-Asian populations.Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysisType 2 diabetes: uses of thiazolidinediones and insulin.Comparison of non-insulin antidiabetic agents as an add-on drug to insulin therapy in type 2 diabetes: a network meta-analysis.
P2860
Q33888236-4FB9EA5B-EC3D-4F40-A68E-BACACEDBE792Q34133889-DF011F6B-5FA0-41EC-B0C5-35D672B5A542Q35043812-0FFA5987-9F3B-4F8B-8852-D28B6065ECC3Q36487362-580C8468-0E5C-4DAD-AC93-BEA4DB78D35FQ37309905-2AD6DF10-E985-4ABC-84E3-9FD523FEECE0Q38957754-CB682FAC-AD94-41AF-9F19-99EA78FA66CDQ39350860-D46B3A3E-274B-4727-B4FD-9E6DA947E7D7Q39420555-B391989D-E634-42B3-AD50-2BE019A5CC60Q42003332-4B9807B6-C74C-4A6E-8BD5-EFE5E205EE0FQ42576525-84DDAF00-8CDD-4939-AF8E-C4CB7A35A996Q51245889-66E6BB20-2082-4EF4-AF44-2D876858C276
P2860
Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Comparison of insulin monother ...... d acarbose in type 2 diabetes.
@en
Comparison of insulin monother ...... d acarbose in type 2 diabetes.
@nl
type
label
Comparison of insulin monother ...... d acarbose in type 2 diabetes.
@en
Comparison of insulin monother ...... d acarbose in type 2 diabetes.
@nl
prefLabel
Comparison of insulin monother ...... d acarbose in type 2 diabetes.
@en
Comparison of insulin monother ...... d acarbose in type 2 diabetes.
@nl
P2093
P921
P1433
P1476
Comparison of insulin monother ...... d acarbose in type 2 diabetes.
@en
P2093
Alptekin Gursoy
Hamiyet Yilmaz
Mustafa Sahin
Nilgun Guvener Demirag
P2888
P304
P356
10.1007/S00592-007-0004-9
P577
2007-08-29T00:00:00Z